Kintor Pharmaceutical Limited (HKG:9939)
Hong Kong · Delayed Price · Currency is HKD 1.700
+0.060 (3.66%)
Jul 31, 2026, 4:08 PM HKT
Kintor Pharmaceutical Market Cap
Kintor Pharmaceutical has a market cap or net worth of 839.48 million as of July 31, 2026. Its market cap has decreased by -23.28% in one year.
Market Cap
839.48M
Enterprise Value
899.41M
Revenue
36.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.70
ChartMarket Cap Chart
Since May 22, 2020, Kintor Pharmaceutical's market cap has decreased from 7.94B to 839.48M, a decrease of -89.43%. That is a compound annual growth rate of -30.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 839.48M | -13.22% |
| Dec 31, 2025 | 967.31M | 130.32% |
| Dec 31, 2024 | 419.98M | -42.42% |
| Dec 29, 2023 | 729.42M | -83.45% |
| Dec 30, 2022 | 4.41B | -7.54% |
| Dec 31, 2021 | 4.77B | 23.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 22, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beijing Biostar Pharmaceuticals | 1.29B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.26B |
| CANbridge Pharmaceuticals | 1.18B |
| Cloudbreak Pharma | 971.25M |
| Sunho Biologics | 970.43M |
| Cutia Therapeutics | 872.08M |
| Wuhan YZY Biopharma | 715.30M |
| Brii Biosciences | 671.28M |